Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common form of dementia. The development of assay technologies able to diagnose early-stage AD is important. Blood tests to detect biomarkers, such as amyloid and total Tau protein, are among the most promising diagnostic methods due to their low cost, low risk,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shieh-Yueh, Chiu, Ming-Jang, Chen, Ta-Fu, Horng, Herng-Er
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520821/
https://www.ncbi.nlm.nih.gov/pubmed/28733955
http://dx.doi.org/10.1007/s40120-017-0075-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520821/
https://www.ncbi.nlm.nih.gov/pubmed/28733955
http://dx.doi.org/10.1007/s40120-017-0075-7

Ejemplares similares